Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Removing Lipemia in Serum/Plasma Samples: A Multicenter Study

  • Received : 2017.11.12
  • Accepted : 2018.06.20
  • Published : 2018.11.01
⟨ Previous Next ⟩

Abstract

Background: Lipemia, a significant source of analytical errors in clinical laboratory settings, should be removed prior to measuring biochemical parameters. We investigated whether lipemia in serum/plasma samples can be removed using a method that is easier and more practicable than ultracentrifugation, the current reference method. Methods: Seven hospital laboratories in Spain participated in this study. We first compared the effectiveness of ultracentrifugation ($108,200{\times}g$) and high-speed centrifugation ($10,000{\times}g$ for 15 minutes) in removing lipemia. Second, we compared high-speed centrifugation with two liquid-liquid extraction methods-LipoClear (StatSpin, Norwood, USA), and 1,1,2-trichlorotrifluoroethane (Merck, Darmstadt, Germany). We assessed 14 biochemical parameters: serum/plasma concentrations of sodium ion, potassium ion, chloride ion, glucose, total protein, albumin, creatinine, urea, alkaline phosphatase, gamma-glutamyl transferase, alanine aminotransferase, aspartate-aminotransferase, calcium, and bilirubin. We analyzed whether the differences between lipemia removal methods exceeded the limit for clinically significant interference (LCSI). Results: When ultracentrifugation and high-speed centrifugation were compared, no parameter had a difference that exceeded the LCSI. When high-speed centrifugation was compared with the two liquid-liquid extraction methods, we found differences exceeding the LCSI in protein, calcium, and aspartate aminotransferase in the comparison with 1,1,2-trichlorotrifluoroethane, and in protein, albumin, and calcium in the comparison with LipoClear. Differences in other parameters did not exceed the LCSI. Conclusions: High-speed centrifugation ($10,000{\times}g$ for 15 minutes) can be used instead of ultracentrifugation to remove lipemia in serum/plasma samples. LipoClear and 1,1,2-trichlorotrifluoroethane are unsuitable as they interfere with the measurement of certain parameters.

Keywords

References

  1. Kroll M. Evaluating interference caused by lipaemia. Clin Chem 2004;50:1968-9. https://doi.org/10.1373/clinchem.2004.038075
  2. Farrell CL and Carter AC. Serum indices : managing assay interference. Ann Clin Biochem 2016;53:527-38. https://doi.org/10.1177/0004563216643557
  3. Ryder KW, Glick MR, (Ascp) M, Glick SJ. Incidence and amount of turbidity, hemolysis, and icterus in serum from outpatients. Lab Med 1991;22:415-8. https://doi.org/10.1093/labmed/22.6.415
  4. Nikolac N. Lipaemia: causes, interference mechanisms, detection and management. Biochem Med 2014;24:57-67.
  5. Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003; 332:11-9. https://doi.org/10.1016/S0009-8981(03)00129-3
  6. Calmarza P and Cordero J. Lipaemia interferences in routine clinical biochemical tests. Biochem Med 2011;21:160-6.
  7. Walker PL and Crook MA. Lipaemia: causes, consequences and solutions. Clin Chim Acta 2013;418:30-2. https://doi.org/10.1016/j.cca.2012.12.029
  8. Dimeski G. Interference testing. Clin Biochem Rev 2008;29(S1):S43-8.
  9. Dimeski G and Jones BW. Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation. Biochem Med (Zagreb) 2011;21:86-92.
  10. CLSI. Hemolysis, icterus, and lipaemia/turbidity indices as indicators of interference in clinical laboratory analysis. 1st ed. CLSI C56. Wayne, PA: Clinical and Laboratory Standards Institute. 2011.
  11. Vermeer HJ, Steen G, Naus JM, Goevaerts B, Pauline T, Schoenmakers CHH. Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids : a practical approach. Clin Chem Lab Med 2007;45:114-9.
  12. Saracevic A, Nikolac N, Simundic A. The evaluation and comparison of consecutive high speed centrifugation and $LipoClear^{(R)}$ reagent for lipaemia removal. Clin Biochem 2014;47:309-14. https://doi.org/10.1016/j.clinbiochem.2014.01.001
  13. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 1986;24:481-95.
  14. Bergmeyer HU, Horder M, Rej R. Approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC Method for aspartate aminotransferase. J Clin Chem Clin Biochem 1986;24:497-510.
  15. Tietz NW, Rinker AD, Shaw LM. International Federation of Clinical Chemistry. IFCC methods for the measurement of catalytic concentration of enzymes, Part 5. IFCC method for alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem 1983;21:731-48.
  16. Szasz G. New substrates for measuring gamma-glutamyl-transpeptidase activity. Z Klin Chem Klin Biochem 1974;12:228.
  17. Spanish Society of Clinical Biochemistry and Molecular Pathology. Criteria for the assessment of the analytical and clinical significance of interferences in clinical biochemistry. Quim Clinica 1995;14:107-9.
  18. CLSI. Statistical quality control for quantitative measurement procedures: principles and definitions; approved guideline. 3rd Ed. CLSI C24-A3. Wayne, PA: Clinical Laboratory Standards Institute. 2006.

Cited by

  1. Effects of marked hypertriglyceridemia and lipid clearance techniques on canine biochemistry testing vol.31, pp.4, 2018, https://doi.org/10.1177/1040638719858690
  2. Lipemia Interferences in Biochemical Tests, Investigating the Efficacy of Different Removal Methods in comparison with Ultracentrifugation as the Gold Standard vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/9857636
  3. Lipemia: un'interferenza dimenticata? Considerazioni e Raccomandazioni. GdS VEA SIPMeL vol.16, pp.1, 2020, https://doi.org/10.23736/s1825-859x.20.00052-3
  4. A Thirteen-Year-Old Boy with Rashes and Bumps on Arms and Legs vol.5, pp.5, 2018, https://doi.org/10.1093/jalm/jfaa055
  5. Use of intravenous lipid emulsion therapy as a novel treatment for brevetoxicosis in sea turtles vol.11, pp.1, 2018, https://doi.org/10.1038/s41598-021-03550-y
  6. Rapid preparation of human blood plasma for bottom-up proteomics analysis vol.2, pp.4, 2018, https://doi.org/10.1016/j.xpro.2021.100856
  7. A Simple and Cost-Effective Method for Measuring Hemolysis in Biobank Serum Specimens vol.19, pp.6, 2018, https://doi.org/10.1089/bio.2021.0037
  8. Methods to reduce lipemic interference in clinical chemistry tests: a systematic review and recommendations vol.60, pp.2, 2018, https://doi.org/10.1515/cclm-2021-0979